Skip to main content

Helicos Expects to Report $5M in Q4, Q1 2010 Receipts

This article has been corrected to note that Helicos expects the revenue to be recognized in the fourth quarter of 2009 and first quarter of 2010, rather than in its third quarter of 2009.

NEW YORK (GenomeWeb News) – Helicos BioSciences today said that it expects to report cash receipts of $5 million from systems orders and associated reagent purchases during the fourth quarter of 2009 and first quarter of 2010.

"In the third quarter of 2009, we continued to accelerate the deployment of our Helicos Genetic Analysis System and to advance our technology," Helicos CEO Ronald Lowy said in a statement. "System orders more than doubled during the third quarter of 2009 compared to the first half of 2009, which resulted in an increase in the number of System installations from six to eleven during the quarter."

The firm said that it expects to file its third-quarter report with the US Securities and Exchange Commission on or before Nov. 14.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.